Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02036086
Title Study of Neo-adjuvant Use of Vemurafenib Plus Cobimetinib for BRAF Mutant Melanoma With Palpable Lymph Node Metastases
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Sunnybrook Health Sciences Centre



Cobimetinib + Vemurafenib

Age Groups: adult
Covered Countries CAN

Facility Status City State Zip Country Details
The Ottawa Hospital - General Campus Ottawa Ontario K1H 8L6 Canada Details
Sunnybrook Health Sciences Centre Toronto Ontario M4N 3M5 Canada Details
Royal Victoria Hospital Montreal Quebec H3A 1A1 Canada Details
*Shaded cells indicate that there was no data available from for the field